Icell Gene Therapeutics
Clinical trials sponsored by Icell Gene Therapeutics, explained in plain language.
-
Engineered immune cells take aim at lupus in early trial
Disease control Not yet recruitingThis early-stage trial tests a one-time infusion of specially designed immune cells (CAR T cells) in 20 people with severe lupus that hasn't responded to standard treatments. The cells target two proteins (BCMA and CD19) to help reset the immune system and reduce disease activity…
Phase: PHASE1, PHASE2 • Sponsor: iCell Gene Therapeutics • Aim: Disease control
Last updated May 01, 2026 09:25 UTC
-
Engineered immune cells aim to tame stubborn IBD
Disease control Not yet recruitingThis early-phase study tests a new treatment called ICG318 CAR-T for people with inflammatory bowel disease (IBD) that hasn't responded to standard therapies. The treatment uses a patient's own immune cells, modified in a lab to target and calm the overactive immune response caus…
Phase: PHASE1, PHASE2 • Sponsor: iCell Gene Therapeutics • Aim: Disease control
Last updated Apr 30, 2026 15:52 UTC